TickerFactsScreenerDevelopers

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$8.60M2010: -$13.73M2011: -$17.20M2012: -$11.26M2017: -$10.35M2018: -$5.20M2019: -$6.19M2020: -$4.09M2021: -$1.01M2022: -$3.04M2023: -$2.57M2024: -$3.28M2025: -$3.33M-$3.33M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.33M-1.3%
2024-$3.28M-27.7%
2023-$2.57M+15.4%
2022-$3.04M-200.2%
2021-$1.01M+75.2%
2020-$4.09M+34.0%
2019-$6.19M-18.9%
2018-$5.20M+49.7%
2017-$10.35M—
2012-$11.26M+34.5%
2011-$17.20M-25.3%
2010-$13.73M-59.7%
2009-$8.60M—